# Butterfly Needle Set Market > Butterfly Needle Set Market Research Report By Needle Gauge (19G, 21G, 23G, 25G, 27G), By Material (Stainless Steel, Polypropylene, Polyethylene), By Safety Mechanism (Retractable Needle, Non-Retractable Needle), By Application (Blood Collection, Intravenous Therapy, Subcutaneous Injections), By End User (Hospitals and Clinics, Home Healthcare, Veterinary Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 3.77% - **2024:** $ 0.85 Billion - **2025:** $ 0.88 Billion - **2035:** $ 1.28 Billion - **Key Players:** Becton Dickinson and Company (US), Terumo Corporation (JP), Smiths Medical (US), Nipro Corporation (JP), Medtronic plc (IE), Fresenius Kabi AG (DE), Vygon S.A. (FR), Halyard Health, Inc. (US), B. Braun Melsungen AG (DE) **Report ID:** MRFR/HC/27417-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/butterfly-needle-set-market-29124 --- ## Market Summary ## **Butterfly Needle Set Market Overview** As per MRFR analysis, the Butterfly Needle Set Market Size was estimated at 0.85 (USD Billion) in 2024. The Butterfly Needle Set Market Industry is expected to grow from 0.88 (USD Billion) in 2025 to 1.23 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.77% during the forecast period (2025 - 2034). **Key Butterfly Needle Set Market Trends Highlighted** Butterfly needle sets, designed for intravenous and subcutaneous injections, are gaining prominence in healthcare settings. Driven by the increasing prevalence of chronic diseases and the growing need for minimally invasive procedures, the butterfly needle set market is poised for significant growth in the coming years. The rising demand for precision in drug delivery and patient comfort is fueling the adoption of butterfly needle sets, which offer accurate injections and reduce discomfort compared to traditional needles. Technological advancements, such as the development of safety features like needle shields and ergonomic designs, are also driving market growth. Moreover, the growing use of butterfly needle sets in home and ambulatory care settings provides significant opportunities for market expansion. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Butterfly Needle Set Market Drivers** Increasing Prevalence of Chronic Diseases Chronic diseases such as diabetes, cancer, and kidney disease are on the rise globally. These conditions often require frequent blood draws and injections, which has led to an increased demand for butterfly needle sets. Butterfly needles are less painful and easier to use than traditional needles, making them an ideal choice for patients who require frequent blood draws or injections. The increasing prevalence of chronic diseases is a major factor driving the growth of the butterfly needle set market. Growing Demand for Minimally Invasive Procedures Minimally invasive procedures are becoming increasingly popular as they offer a number of advantages over traditional open surgery. These procedures require the use of smaller needles and incisions, which has created a demand for butterfly needle sets. Butterfly needles are ideal for minimally invasive procedures because they are less traumatic and reduce the risk of complications. The growing demand for minimally invasive procedures is another major factor driving the growth of the butterfly needle set market. Technological Advancements Technological advancements are also contributing to the growth of the butterfly needle set market. The development of new needle designs and materials has made butterfly needles more effective and easier to use. For example, some butterfly needles are now coated with a special lubricant that reduces pain during insertion. Other butterfly needles are designed with a safety feature that prevents accidental needle sticks. These technological advancements are making butterfly needle sets more attractive to patients and healthcare professionals. **Butterfly Needle Set Market Segment Insights:** **Butterfly Needle Set Market Needle Gauge Insights** The Needle Gauge segment of the Butterfly Needle Set Market is categorized into 19G, 21G, 23G, 25G, and 27G. Among these, the 23G segment is projected to dominate the market, accounting for a revenue share of around 35% in 2024. This dominance can be attributed to the widespread use of 23G needles in various clinical applications, including blood collection, injections, and IV therapy. Furthermore, the growing demand for minimally invasive procedures is expected to fuel the demand for 23G butterfly needles. The 25G segment is anticipated to witness a steady growth rate over the forecast period. The increasing prevalence of chronic diseases, such as diabetes and anemia, is driving the demand for frequent blood draws. As 25G needles are commonly used for these procedures, the segment is expected to benefit from this trend. The 19G and 21G segments are also projected to experience significant growth, owing to their suitability for larger blood draws and injections. These needles are often used in emergency situations, blood transfusions, and the administration of medications that require higher flow rates. The 27G segment is expected to account for a smaller share of the market compared to the other segments. This can be attributed to its limited use in specific applications, such as pediatric care and fragile veins. However, the segment is expected to witness a stable growth rate due to its advantages in minimizing pain and discomfort during injections. Overall, the Needle Gauge segment of the Butterfly Needle Set Market is expected to exhibit steady growth over the coming years, driven by the increasing demand for minimally invasive procedures, the rising prevalence of chronic diseases, and the growing adoption of advanced healthcare technologies. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Butterfly Needle Set Market Material Insights** The Butterfly Needle Set Market is segmented by Material into Stainless Steel, Polypropylene, and Polyethylene. The Stainless-Steel segment holds the largest market share due to its durability, corrosion resistance, and ability to withstand repeated sterilization. The Polypropylene segment is expected to grow at a significant rate due to its low cost, lightweight, and flexibility. The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and growing awareness about the benefits of butterfly needle sets. **Butterfly Needle Set Market Safety Mechanism Insights** The Safety Mechanism segment plays a crucial role in the Butterfly Needle Set Market, offering distinct features and benefits to healthcare professionals. Retractable Needle and Non-Retractable Needle are the two primary types of Safety Mechanisms available in the market. Retractable Needle sets feature a protective sheath that automatically covers the needle after use, reducing the risk of needlestick injuries for healthcare workers. Non-Retractable Needle sets, on the other hand, do not have a retractable mechanism, making them more cost-effective but posing a higher risk of accidental needle sticks. In 2023, the Retractable Needle segment held the dominant share in the Butterfly Needle Set Market revenue, accounting for approximately 60%. The growing emphasis on safety in healthcare settings and government regulations mandating the use of safety-engineered medical devices have contributed to this dominance. The Non-Retractable Needle segment is projected to witness a steady growth rate, primarily driven by its lower cost compared to Retractable Needles. The Butterfly Needle Set Market segmentation provides valuable insights into the market dynamics, enabling manufacturers to tailor their product offerings and strategies accordingly. This data empowers stakeholders to make informed decisions and capitalize on growth opportunities within the industry. **Butterfly Needle Set Market Application Insights** The Application segment of the Butterfly Needle Set Market holds significant importance, influencing market growth and dynamics. Blood Collection, Intravenous Therapy, and Subcutaneous Injections are the key applications driving the market's expansion. Blood Collection accounted for the largest revenue share in the Butterfly Needle Set Market in 2023, owing to its widespread use in medical facilities and laboratories for collecting blood samples for diagnostic purposes. The increasing prevalence of chronic diseases and the growing demand for regular blood monitoring contribute to the segment's growth. Intravenous Therapy is another major application, accounting for a substantial market share. Butterfly needle sets are commonly used in hospitals, clinics, and home healthcare settings for administering intravenous fluids, medications, and nutrients directly into the bloodstream. The rising incidence of infectious diseases and the increasing number of patients requiring intravenous treatment drive the segment's expansion. Subcutaneous Injections, used to deliver medications or fluids beneath the skin, also contribute to the Butterfly Needle Set Market growth. This application is gaining traction due to the growing prevalence of diabetes, autoimmune disorders, and other conditions requiring self-administered injections. Overall, the Application segment offers valuable insights into the specific end-uses of Butterfly Needle Sets, highlighting the key factors influencing demand and growth opportunities within the Butterfly Needle Set Market. **Butterfly Needle Set Market End User Insights** The Butterfly Needle Set Market is segmented by end user into hospitals and clinics, home healthcare, and veterinary clinics. Hospitals and clinics were the largest end user segment, accounting for over 60% of the global market revenue in 2023. The growth of this segment is attributed to the increasing number of surgeries and invasive procedures performed in hospitals and clinics. Home healthcare is likely to be the fastest-growing end user segment, with a projected CAGR of over 4% from 2024 to 2032. This growth is driven by the rising demand for home healthcare services, such as infusion therapy and blood transfusions, due to the increasing prevalence of chronic diseases and the growing elderly population. Veterinary clinics are a relatively small end user segment, but they are expected to experience steady growth over the forecast period due to the increasing number of companion animals and the rising demand for veterinary care. **Butterfly Needle Set Market Regional Insights** The Butterfly Needle Set Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest share of the market in 2023 and is expected to continue to dominate the market throughout the forecast period. The growth of the North American market is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and favorable reimbursement policies. Europe is the second largest market for butterfly needle sets, with a significant presence of major manufacturers and a well-established healthcare system. The APAC region is expected to witness the fastest growth over the forecast period, due to the increasing healthcare expenditure, rising population, and growing awareness of minimally invasive procedures. South America and MEA are expected to have a relatively smaller market share but are expected to grow steadily over the forecast period. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Butterfly Needle Set Market Key Players and Competitive Insights:** Major players in the Butterfly Needle Set Market are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolio, and acquiring smaller players. Leading Butterfly Needle Set Market players are focusing on developing innovative products that cater to the specific needs of end-users, such as those with diabetes or other chronic conditions that require frequent injections. The Butterfly Needle Set Market development is also being driven by the increasing adoption of home healthcare services, which is leading to a growing demand for disposable and easy-to-use medical devices. The competitive Landscape of Butterfly Needle Set Market is expected to remain highly competitive in the coming years, with major players continuing to invest in new technologies and products to maintain their market share. Becton, Dickinson and Company is a leading medical technology company that manufactures and markets a wide range of medical devices, including Butterfly Needle Set. The company has a strong presence in the Butterfly Needle Set Market, with a wide distribution network and a strong brand reputation. Becton, Dickinson and Company is known for its high-quality products and its commitment to innovation. The company is also actively involved in research and development, and it has a number of new products in the pipeline that are expected to be launched in the coming years. Terumo Medical Corporation is another major player in the Butterfly Needle Set Market. The company manufactures and markets a wide range of medical devices, including blood transfusion sets, IV therapy sets, and Butterfly Needle Set. Terumo Medical Corporation has a strong presence in the Butterfly Needle Set Market, with a wide distribution network and a strong brand reputation. The company is known for its high-quality products and its commitment to customer service. Terumo Medical Corporation is also actively involved in research and development, and it has a number of new products in the pipeline that are expected to be launched in the coming years. **Key Companies in the Butterfly Needle Set Market Include:** **Butterfly Needle Set Market Developments** _The increasing prevalence of chronic diseases, such as diabetes, and the growing adoption of minimally invasive procedures are key factors driving market growth._ _The rising geriatric population and the increasing demand for home healthcare services are also contributing to the market expansion. Furthermore, technological advancements, such as the development of atraumatic needles and safety features, are expected to propel market growth in the coming years._ _Key players in the market include Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, and Nipro Corporation. In 2023, the market was valued at USD 0.79 billion._ **Butterfly Needle Set Market Segmentation Insights** **Butterfly Needle Set Market Needle Gauge Outlook** **Butterfly Needle Set Market Material Outlook** **Butterfly Needle Set Market Safety Mechanism Outlook** **Butterfly Needle Set Market Application Outlook** **Butterfly Needle Set Market End User Outlook** **Butterfly Needle Set Market Regional Outlook** ## Market Drivers ### Increasing Geriatric Population The Butterfly Needle Set Market is poised for growth due to the increasing geriatric population, which is more susceptible to health issues requiring frequent medical interventions. As the global population aged 65 and older is expected to double by 2050, the demand for medical devices that facilitate easier venous access is likely to rise. Butterfly needles are particularly advantageous for elderly patients, as they minimize discomfort and reduce the risk of complications. This demographic shift suggests a sustained demand for butterfly needle sets, as healthcare systems adapt to the needs of an aging population. ### Rising Prevalence of Chronic Diseases The Butterfly Needle Set Market is experiencing growth due to the increasing prevalence of chronic diseases such as diabetes and cardiovascular disorders. As these conditions require frequent blood sampling and intravenous access, the demand for butterfly needles, known for their ease of use and patient comfort, is likely to rise. According to recent data, the incidence of diabetes alone is projected to reach 700 million cases by 2045, which could significantly boost the need for butterfly needle sets. This trend indicates a sustained demand for these medical devices, as healthcare providers seek efficient solutions for managing chronic conditions. ### Technological Innovations in Medical Devices The Butterfly Needle Set Market is influenced by ongoing technological innovations that enhance the functionality and safety of medical devices. Recent advancements include the development of safety-engineered butterfly needles that reduce the risk of needlestick injuries. These innovations are crucial, as needlestick injuries pose significant health risks to healthcare workers. The market for safety-engineered devices is anticipated to grow, with estimates suggesting a market size of over 5 billion USD by 2026. This growth indicates a shift towards safer medical practices, further driving the demand for butterfly needle sets. ### Growing Focus on Minimally Invasive Procedures The Butterfly Needle Set Market is benefiting from a growing emphasis on minimally invasive procedures across various medical fields. These procedures are preferred for their reduced recovery times and lower risk of complications. Butterfly needles, with their design that allows for precise access to veins, are increasingly utilized in outpatient settings and for pediatric patients. The market for minimally invasive devices is expected to expand, with projections indicating a compound annual growth rate of over 10% in the coming years. This trend suggests that butterfly needle sets will play a crucial role in the evolution of medical practices. ### Enhanced Training and Education for Healthcare Professionals The Butterfly Needle Set Market is also being driven by enhanced training and education programs for healthcare professionals. As the healthcare landscape evolves, there is a growing emphasis on proper techniques for venipuncture and the use of butterfly needles. Training initiatives aim to improve patient outcomes and reduce complications associated with blood draws. With an increasing number of healthcare institutions adopting comprehensive training programs, the proficiency in using butterfly needle sets is likely to improve. This focus on education may lead to a higher adoption rate of these devices in clinical settings. ## Future Outlook The Butterfly Needle Set Market is projected to grow at a 3.77% CAGR from 2025 to 2035, driven by increasing demand for minimally invasive procedures and advancements in medical technology. **New opportunities:** - Expansion into emerging markets with tailored product offerings. - Development of eco-friendly butterfly needle materials to attract sustainability-focused healthcare providers. - Integration of smart technology for real-time monitoring and data collection during procedures. By 2035, the Butterfly Needle Set Market is expected to achieve robust growth, reflecting evolving healthcare needs. ## Segment Insights ### By Needle Gauge: 21G (Largest) vs. 23G (Fastest-Growing) In the Butterfly Needle Set Market, the distribution of market share among needle gauges reveals that the 21G gauge dominates the segment, appealing to a wide range of applications from pediatric to general use. This increased preference for the 21G needle is attributed to its versatility and balance between comfort and performance, making it a preferred choice among healthcare providers. Meanwhile, the 23G gauge is showing promising growth, driven by increased demand for less invasive procedures and the trend towards enhanced patient comfort. The growth of the 23G gauge segment is primarily stimulated by advancements in technology that enhance needle design and improve user experience. As the healthcare sector increasingly prioritizes patient-centric strategies and minimally invasive treatment options, the 23G gauge has emerged as a favorable choice for clinicians seeking to reduce patient trauma. The continuous evolution of healthcare practices, along with positive feedback from users, indicates a strong upward trajectory for the 23G gauge segment in the coming years. 21G (Dominant) vs. 25G (Emerging) The 21G needle gauge remains the dominant player in the Butterfly Needle Set Market, celebrated for its substantial applicability and effectiveness in various clinical settings. Its adoption is notably high, as it strikes a fine balance between sufficient lumen size for blood flow and minimal discomfort for patients. The gauge is widely utilized not only for routine venipunctures but also in special scenarios requiring reliability. Conversely, the 25G gauge has marked its presence as an emerging segment, appealing particularly to procedures that necessitate finer needles and reduced tissue trauma. The growing emphasis on less invasive techniques in medical practices supports the rise of the 25G gauge, making it increasingly favored in pediatric care and those requiring enhanced patient comfort. This dynamic between dominant and emerging gauges reflects evolving clinical preferences. ### By Material: Stainless Steel (Largest) vs. Polypropylene (Fastest-Growing) In the Butterfly Needle Set Market, the material composition plays a decisive role in product performance and consumer preference. Stainless steel currently dominates the market due to its durability, biocompatibility, and ease of sterilization. It forms the backbone of butterfly needle production due to its superior mechanical properties, making it the preferred choice for healthcare institutions and professionals worldwide. On the other hand, polypropylene is gaining traction for its lightweight characteristics and cost-effectiveness, appealing to budget-conscious buyers in the market. The growth trends in this segment reveal an increasing demand for versatile and high-performance materials. The rising awareness of infection control and advancements in medical technology contribute to the preference for stainless steel. Meanwhile, the ongoing innovations in plastics and the development of biodegradable polypropylene variants are driving growth in the polypropylene segment, indicating a shifting consumer base that values both sustainability and functionality. Material: Stainless Steel (Dominant) vs. Polypropylene (Emerging) Stainless steel is characterized by its strength, resistance to corrosion, and capability to withstand repeated sterilization processes, which positions it as the dominant material in the Butterfly Needle Set Market. It is widely recognized for providing reliable performance and ensuring patient safety, thus preferred in critical applications. Conversely, polypropylene is emerging as a viable alternative due to its lightweight and flexible nature. It offers a considerable reduction in production costs and appeals to manufacturers aiming to create budget-friendly medical devices. This shift towards polypropylene is bolstered by innovation in its formulation to enhance its mechanical properties and improve patient experiences while using butterfly needles. ### By Safety Mechanism: Retractable Needle (Largest) vs. Non-Retractable Needle (Fastest-Growing) In the Butterfly Needle Set Market, the segment for safety mechanisms is primarily dominated by retractable needles, which hold the largest share due to their enhanced safety features that minimize needlestick injuries. These needles are preferred by healthcare providers for their ease of use and effective retraction mechanisms that contribute to overall patient and staff safety. Conversely, non-retractable needles are gaining attention as an emerging alternative, particularly in markets seeking cost-effective solutions while ensuring basic safety measures. Safety Mechanism: Retractable Needle (Dominant) vs. Non-Retractable Needle (Emerging) Retractable needles are positioned as the dominant safety mechanism in the Butterfly Needle Set Market, appreciated for their innovative design that allows for the safe retraction of the needle after use. This feature significantly reduces the risk of accidental needlestick injuries, which are a major concern in medical environments. In contrast, non-retractable needles, while historically more conventional, are emerging in the market as a competitive option. They appeal to healthcare providers looking for more budget-friendly alternatives that still maintain a basic level of safety. However, their lack of advanced safety features can limit their attractiveness compared to retractable variants. ### By Application: Blood Collection (Largest) vs. Intravenous Therapy (Fastest-Growing) In the Butterfly Needle Set Market, the application segment showcases a diverse range of uses, with Blood Collection being the largest due to its extensive demand in laboratory and clinical settings. Blood Collection is essential for diagnostic testing and monitoring health conditions, making it a primary choice among healthcare providers. Following closely behind, Intravenous Therapy has emerged as the fastest-growing segment, driven by the increasing prevalence of chronic diseases and the need for efficient drug delivery systems. Blood Collection (Dominant) vs. Intravenous Therapy (Emerging) Blood Collection remains the dominant application in the Butterfly Needle Set Market, primarily due to its significance in diagnostics and patient monitoring. This segment benefits from established practices and a robust demand for reliable blood sampling methodologies. Intravenous Therapy, categorized as an emerging application, is gaining ground rapidly, fueled by advancements in medical technology and the rising incidence of conditions requiring intravenous treatments. As healthcare providers prioritize patient comfort and procedure efficiency, the adoption of butterfly needle sets for IV therapy continues to increase, highlighting a promising shift in the healthcare landscape. ### By End User: Hospitals and Clinics (Largest) vs. Home Healthcare (Fastest-Growing) In the Butterfly Needle Set Market, the segmentation by end user reveals that hospitals and clinics occupy a substantial share of the market. This segment is characterized by high demand due to the frequency of procedures that require butterfly needles, primarily for blood collection and intravenous therapy. Home healthcare is also a significant segment, reflecting the growing trend of personalized care outside traditional medical settings. Combined, these two segments illustrate the diverse applications and importance of butterfly needle sets in various healthcare environments. The growth trends in the Butterfly Needle Set Market indicate a notable shift towards home healthcare, making it the fastest-growing segment. This shift is driven by the increasing preference for at-home medical treatments, alongside an aging population that requires regular blood tests and therapies without the need for frequent hospital visits. Hospitals and clinics, while remaining the largest segment, are continually adapting to advances in needle technology and patient needs, maintaining their pivotal role in healthcare delivery. Hospitals and Clinics (Dominant) vs. Home Healthcare (Emerging) In the Butterfly Needle Set Market, hospitals and clinics are regarded as the dominant players due to their established infrastructure and the high volume of patients requiring needle-based interventions. Their operational effectiveness relies on the systematic use of butterfly needles for safe and efficient blood collection and medication administration. Conversely, the home healthcare segment represents an emerging market with rapidly increasing demand. This growth is fueled by the rise in chronic illnesses and patient preferences for convenient care options. Both segments are essential, yet their characteristics differ, as hospitals focus on acute care while home healthcare emphasizes patient comfort and accessibility, fostering a need for innovative needle technologies suitable for use outside hospital settings. ## Regional Market Share Analysis ### North America : Healthcare Innovation Leader North America is the largest market for butterfly needle sets, accounting for approximately 45% of the global market share. The region's growth is driven by increasing healthcare expenditures, a rise in chronic diseases, and advancements in medical technology. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical devices. The demand for minimally invasive procedures is also on the rise, contributing to market growth. The United States is the leading country in this region, with a significant presence of key players such as Becton Dickinson and Company and Smiths Medical. The competitive landscape is characterized by innovation and strategic partnerships among major companies. Canada also plays a vital role, with increasing investments in healthcare infrastructure and a growing awareness of advanced medical devices. Overall, the North American market is poised for continued growth, driven by technological advancements and a robust healthcare system. ### Europe : Regulatory Framework and Growth Europe is the second-largest market for butterfly needle sets, holding approximately 30% of the global market share. The region's growth is fueled by an aging population, increasing prevalence of chronic diseases, and a strong emphasis on patient safety and comfort. Regulatory frameworks, such as the Medical Device Regulation (MDR), ensure high standards for medical devices, promoting innovation and market entry for new products. The demand for minimally invasive procedures is also a significant driver in this region. Leading countries in Europe include Germany, France, and the United Kingdom, where key players like Fresenius Kabi AG and B. Braun Melsungen AG are prominent. The competitive landscape is marked by a focus on product innovation and strategic collaborations among manufacturers. The presence of well-established healthcare systems and a growing emphasis on patient-centric care further enhance market opportunities. Overall, the European market is expected to witness steady growth, supported by regulatory advancements and increasing healthcare investments. ### Asia-Pacific : Emerging Market Potential Asia-Pacific is an emerging powerhouse in the butterfly needle set market, accounting for approximately 20% of the global market share. The region's growth is driven by increasing healthcare investments, a rising population, and a growing prevalence of chronic diseases. Countries like China and India are witnessing rapid urbanization and improvements in healthcare infrastructure, which are significant catalysts for market expansion. Additionally, government initiatives aimed at enhancing healthcare access further support market growth. China and Japan are the leading countries in this region, with a strong presence of key players such as Terumo Corporation and Nipro Corporation. The competitive landscape is evolving, with local manufacturers gaining traction alongside established global players. The increasing adoption of advanced medical technologies and a focus on patient comfort are shaping market dynamics. Overall, the Asia-Pacific market is poised for substantial growth, driven by demographic changes and healthcare advancements. ### Middle East and Africa : Untapped Market Opportunities The Middle East and Africa region is witnessing a gradual increase in the butterfly needle set market, holding approximately 5% of the global market share. The growth is primarily driven by rising healthcare expenditures, increasing awareness of advanced medical technologies, and a growing prevalence of chronic diseases. Government initiatives aimed at improving healthcare infrastructure and access to medical devices are also contributing to market expansion. The region's diverse healthcare needs present unique opportunities for growth. Leading countries in this region include South Africa and the UAE, where there is a growing presence of key players and local manufacturers. The competitive landscape is characterized by a mix of international and regional companies striving to meet the increasing demand for medical devices. The focus on improving healthcare services and patient outcomes is driving innovation and investment in the market. Overall, the Middle East and Africa market is expected to grow steadily, supported by ongoing healthcare reforms and investments. ## Competitive Benchmarking The Butterfly Needle Set Market is characterized by a dynamic competitive landscape, driven by increasing demand for minimally invasive procedures and advancements in medical technology. Key players such as Becton Dickinson and Company (US), Terumo Corporation (JP), and Medtronic plc (IE) are strategically positioned to leverage innovation and expand their market presence. Becton Dickinson and Company (US) focuses on enhancing product offerings through continuous research and development, while Terumo Corporation (JP) emphasizes regional expansion and partnerships to strengthen its distribution network. Medtronic plc (IE) appears to be concentrating on digital transformation initiatives, integrating [advanced technologies](https://www.marketresearchfuture.com/reports/advanced-technologies-market-41462) into its product lines, which collectively shapes a competitive environment that is increasingly reliant on technological advancements and strategic collaborations.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of global economic fluctuations. The market structure is moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for niche players to emerge, yet the collective strength of major companies ensures that competition remains robust and innovation-driven. In August Becton Dickinson and Company (US) announced the launch of a new line of butterfly needles designed specifically for pediatric patients, which underscores their commitment to addressing specific market needs. This strategic move not only enhances their product portfolio but also positions them favorably in a segment that requires specialized solutions, potentially increasing their market share among healthcare providers focused on pediatric care. In September Terumo Corporation (JP) entered into a strategic partnership with a leading telehealth platform to integrate remote monitoring capabilities into their butterfly needle systems. This collaboration is indicative of a broader trend towards digital health solutions, suggesting that Terumo is keen on enhancing patient outcomes through technology, thereby differentiating itself in a competitive market. In October Medtronic plc (IE) unveiled a new AI-driven analytics tool aimed at optimizing the use of butterfly needles in clinical settings. This innovation reflects a growing trend towards the integration of artificial intelligence in healthcare, which could significantly improve procedural efficiency and patient safety. By adopting such advanced technologies, Medtronic is likely to set new standards in the market, further solidifying its competitive edge. As of October the Butterfly Needle Set Market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, it is anticipated that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technological advancements, and supply chain reliability, thereby fostering a more resilient and forward-thinking market environment. ## Recent News & Developments _The increasing prevalence of chronic diseases, such as diabetes, and the growing adoption of minimally invasive procedures are key factors driving market growth._ _The rising geriatric population and the increasing demand for home healthcare services are also contributing to the market expansion. Furthermore, technological advancements, such as the development of atraumatic needles and safety features, are expected to propel market growth in the coming years._ _Key players in the market include Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, and Nipro Corporation. In 2023, the market was valued at USD 0.79 billion._ ## Report Scope | MARKET SIZE 2024 | 0.8493(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 0.8813(USD Billion) | | MARKET SIZE 2035 | 1.276(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.77% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Becton Dickinson and Company (US), Terumo Corporation (JP), Smiths Medical (US), Nipro Corporation (JP), Medtronic plc (IE), Fresenius Kabi AG (DE), Vygon S.A. (FR), Halyard Health, Inc. (US), B. Braun Melsungen AG (DE) | | Segments Covered | Needle Gauge, Material, Safety Mechanism, Application, End User, Regional | | Key Market Opportunities | Growing demand for minimally invasive procedures drives innovation in the Butterfly Needle Set Market. | | Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation and competition in the Butterfly Needle Set market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current market valuation of the Butterfly Needle Set Market?** A: As of 2024, the market valuation of the Butterfly Needle Set Market was 0.8493 USD Billion. **Q: What is the projected market size for the Butterfly Needle Set Market by 2035?** A: The market is projected to reach 1.276 USD Billion by 2035. **Q: What is the expected CAGR for the Butterfly Needle Set Market during the forecast period?** A: The expected CAGR for the Butterfly Needle Set Market from 2025 to 2035 is 3.77%. **Q: Which companies are considered key players in the Butterfly Needle Set Market?** A: Key players in the market include Becton Dickinson and Company, Terumo Corporation, and Smiths Medical, among others. **Q: What are the primary applications of Butterfly Needle Sets?** A: The primary applications include Blood Collection, Intravenous Therapy, and Subcutaneous Injections. **Q: How does the market segment by needle gauge perform?** A: In 2024, the market segment for needle gauges showed values of 0.1693 USD Billion for 19G and 0.254 USD Billion for 21G. **Q: What materials are commonly used in Butterfly Needle Sets?** A: Common materials include Stainless Steel, which had a market value of 0.42465 USD Billion in 2024, and Polypropylene. **Q: What types of safety mechanisms are available in Butterfly Needle Sets?** A: The market segments into Retractable and Non-Retractable Needle safety mechanisms, with values of 0.4246 USD Billion and 0.4247 USD Billion, respectively. **Q: Who are the primary end users of Butterfly Needle Sets?** A: Primary end users include Hospitals and Clinics, which accounted for 0.4246 USD Billion in 2024. **Q: What is the market performance of Butterfly Needle Sets in home healthcare?** A: In 2024, the home healthcare segment was valued at 0.2548 USD Billion, indicating a growing interest in this area. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/butterfly-needle-set-market-29124*